Resonant Clinical Solutions
Resonant Clinical Solutions is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS)
Sponsor Tg Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
An Open Label Extension Study of Ublituximab in Subjects with Relapsing Multiple Sclerosis
Sponsor Tg Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
Pharmacokinetic/pharmacodynamic evaluation of ublituximab in patients with autoimmune diseases
Sponsor Tg Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluating safety, efficacy and pharmacokinetics of a modified regimen of ublituximab (ENHANCE)
Sponsor Tg Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Resonant Clinical Solutions?
The 2026-10-09 snapshot links Resonant Clinical Solutions to 4 distinct CTIS trials. Recorded services include Biological samples archiving, Biological samples storage. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Resonant Clinical Solutions?
The most frequently recorded therapeutic areas are Immunology, Neurology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Resonant Clinical Solutions conducted?
The linked trials record locations in 3 countries, including Poland, Croatia, Slovakia. These are trial locations, not confirmed office locations or countries where Resonant Clinical Solutions delivered services.
What can this page tell me about Resonant Clinical Solutions's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Resonant Clinical Solutions. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Resonant Clinical Solutions